Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Bellavista

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Plos One|March 10, 2012
Charting the NF-κB pathway interactome mapPaolo Tieri, Alberto Termanini, Elena Bellavista, et al.
Ageing Research Reviews|October 3, 2003
Immunoproteasomes and immunosenescenceMichele Mishto, Aurelia Santoro, Elena Bellavista, et al.
Autoimmune Diseases|February 14, 2014
Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosisElena Bellavista, Aurelia Santoro, Daniela Galimberti, et al.
Rejuvenation Research|November 8, 2007
Immunoproteasome in Macaca fascicularis: no age-dependent modification of abundance and activity in the brain and insight into an in silico structural modelElena Bellavista, Michele Mishto, Aurelia Santoro, et al.
Biochemical and Biophysical Research Communications|April 5, 2011
Immunoproteasome expression is induced in mesial temporal lobe epilepsyMichele Mishto, Claudia Ligorio, Elena Bellavista, et al.
Elife|September 23, 2015
Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomesJuliane Liepe, Hermann-Georg Holzhütter, Elena Bellavista, et al.
Nutrition Reviews|June 9, 2017
Mediterranean diet and inflammaging within the hormesis paradigmMorena Martucci, Rita Ostan, Fiammetta Biondi, et al.
Journal of Molecular Biology|March 14, 2008
Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kineticsMichele Mishto, Fabio Luciani, Hermann-Georg Holzhütter, et al.
Current Pharmaceutical Design|September 29, 2012
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?Elena Bellavista, Federico Andreoli, Marco Daniele Parenti, et al.
Current Pharmaceutical Design|January 29, 2008
Different types of cell death in organismal aging and longevity: state of the art and possible systems biology approachStefano Salvioli, Miriam Capri, Paolo Tieri, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Plos One|March 10, 2012
Charting the NF-κB pathway interactome mapPaolo Tieri, Alberto Termanini, Elena Bellavista, et al.
Ageing Research Reviews|October 3, 2003
Immunoproteasomes and immunosenescenceMichele Mishto, Aurelia Santoro, Elena Bellavista, et al.
Autoimmune Diseases|February 14, 2014
Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosisElena Bellavista, Aurelia Santoro, Daniela Galimberti, et al.
Rejuvenation Research|November 8, 2007
Immunoproteasome in Macaca fascicularis: no age-dependent modification of abundance and activity in the brain and insight into an in silico structural modelElena Bellavista, Michele Mishto, Aurelia Santoro, et al.
Biochemical and Biophysical Research Communications|April 5, 2011
Immunoproteasome expression is induced in mesial temporal lobe epilepsyMichele Mishto, Claudia Ligorio, Elena Bellavista, et al.
Elife|September 23, 2015
Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomesJuliane Liepe, Hermann-Georg Holzhütter, Elena Bellavista, et al.
Nutrition Reviews|June 9, 2017
Mediterranean diet and inflammaging within the hormesis paradigmMorena Martucci, Rita Ostan, Fiammetta Biondi, et al.
Journal of Molecular Biology|March 14, 2008
Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kineticsMichele Mishto, Fabio Luciani, Hermann-Georg Holzhütter, et al.
Current Pharmaceutical Design|September 29, 2012
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?Elena Bellavista, Federico Andreoli, Marco Daniele Parenti, et al.
Current Pharmaceutical Design|January 29, 2008
Different types of cell death in organismal aging and longevity: state of the art and possible systems biology approachStefano Salvioli, Miriam Capri, Paolo Tieri, et al.
Pageof 3